Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 1995

Primary Completion Date

July 31, 2000

Study Completion Date

October 31, 2007

Conditions

Osteogenesis Imperfecta

Interventions

OTHER

Bone Marrow Cell Transplantation

RADIATION

Irradiation, Total Body

DRUG

Cyclophosphamide

DRUG

Cyclosporin

PROCEDURE

Mesenchymal Stem Cell Transplantation

DRUG

Busulfan

Trial Locations (1)

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors

lead

St. Jude Children's Research Hospital

OTHER

NCT00705120 - Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation | Biotech Hunter | Biotech Hunter